Biotechnology

Global Cell and Gene Therapy Market Is Estimated To Witness High Growth

Larry Paige

Global Cell and Gene Therapy Market Is Estimated To Witness High Growth

The global Cell and Gene Therapy Market is estimated to be valued at US$ 22.7 Bn in 2023 and is expected to exhibit a CAGR of 28.7% over the forecast period 2023-2030.

A) Market Overview:

Cell and gene therapy involves the use of genes as a therapeutic agent to treat various diseases. It has gained significant attention in recent years due to its potential to offer personalized treatments for patients. Cell therapy involves the transfer of live cells to patients, while gene therapy involves the delivery of therapeutic DNA into patient cells.

These therapies have shown promising results in the treatment of various diseases, including cancer, genetic disorders, cardiovascular diseases, and neurodegenerative diseases. The market for cell and gene therapy is driven by increasing investments in research and development activities, growing collaborations between pharmaceutical companies and research organizations, and the rising prevalence of chronic diseases.

B) Market Dynamics:

1. Increasing Investments in Research and Development: Pharmaceutical companies and research organizations are investing heavily in cell and gene therapy research and development activities. This is driven by the potential of these therapies to revolutionize the treatment landscape for various diseases. For instance, Novartis International AG has invested significant resources in the development of gene therapies, including Kymriah (tisagenlecleucel), which is approved for the treatment of certain types of leukemia.

2. Rising Prevalence of Chronic Diseases: The prevalence of chronic diseases such as cancer, cardiovascular diseases, and genetic disorders is increasing worldwide. Cell and gene therapy hold great promise for the treatment of these diseases by targeting the underlying causes at the cellular and genetic levels. For example, Biogen Inc. has developed Spinraza (nusinersen), a gene therapy for the treatment of spinal muscular atrophy.

C) Market Key Trends:

One key trend observed in the cell and gene therapy market is the increasing focus on partnerships and collaborations between pharmaceutical companies and research organizations. These collaborations aim to accelerate the development and commercialization of cell and gene therapies. For instance, Novartis International AG collaborated with the University of Pennsylvania to develop and commercialize CAR-T cell therapies, including Kymriah.

D) SWOT Analysis:

- Strength: Promising therapeutic potential and increasing investments in research and development.

- Weakness: High treatment costs and complex manufacturing processes.

- Opportunity: Growing demand for personalized medicine and increasing adoption of regenerative medicine approaches.

- Threats: Stringent regulatory requirements and potential safety concerns.

E) Key Takeaways:

Paragraph 1: The global cell and gene therapy market is expected to witness high growth, exhibiting a CAGR of 28.7% over the forecast period, due to increasing investments in research and development and the rising prevalence of chronic diseases.

Paragraph 2: Regional analysis reveals that North America is expected to dominate the cell and gene therapy market, owing to a well-established healthcare infrastructure and the presence of key market players.

Paragraph 3: Key players operating in the global cell and gene therapy market include Novartis International AG, Pfizer, Inc., Sanofi S.A., Amgen, Inc., Regeneron Pharmaceuticals, Inc., Bluebird Bio, Inc., Biogen Inc., uniQure N.V., JCR Pharmaceuticals Co. Ltd., Gene Biotherapeutics, Kolon TissueGene, Inc., Horama S.A., MeiraGTx Limited, Gilead Sciences, Inc., Organogenesis, Inc., Orchard Therapeutics Plc., Freeline Therapeutics Ltd., Bristol-Myers Squibb Company, PTC Therapeutics, Inc., Spark Therapeutics, Inc., and Biomarin Pharmaceutical Inc.

In conclusion, the global cell and gene therapy market is poised for significant growth due to increasing investments in research and development, rising prevalence of chronic diseases, and the potential of these therapies to offer personalized treatments. However, challenges such as high treatment costs and complex manufacturing processes need to be addressed to realize the full potential of cell and gene therapy in healthcare.

Larry Paige

Market Segmentation by Geography in the Cell And Gene Therapy Market

gauri kanale 2023-06-15

When it comes to the market understanding market segmentation by geography is key to identifying unique regional dynamics and tailoring strategies accordingly. The Cell And Gene Therapy Market is a global industry with variations in regulatory frameworks, healthcare infrastructure, and patient demographics across different regions. Each region presents distinct challenges and opportunities that can significantly impact market growth. By analyzing factors such as population size, disease prevalence, and healthcare expenditure, stakeholders can develop targeted approaches to market entry, product positioning, and resource allocation. By actively participating in industry conferences, symposiums, and scientific meetings, companies can showcase their expertise, network with key stakeholders, and stay at the forefront of industry trends.

Cell And Gene Therapy Market 2022-2031 | Business Insights, Trends Analysis, And Forecast

Biswadeep 2022-02-14

With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected cell and gene therapy market growth numbers from 2022-2031. id=3472&type=smp The global cell and gene therapy market is expected to grow from $6. The gene and cell therapy market is expected to reach $21. com/report/cell-and-gene-therapy-global-market-report The Cell And Gene Therapy Global Market Report 2022-31 by The Business Research Company evaluates gene and cell therapy market size, growth rate, drivers, gene and cell therapy industry trends, and major companies. Key Mergers And Acquisitions In The Cell and Gene Therapy Market30.

Cell and Gene Therapy Market to Reach $25.00 Billion by 2027, Reports BIS Research

bisresearch reports 2022-03-01

The premium market intelligence report published by BIS Research titled Global Cell and Gene Therapy Market highlights that the market is projected to reach $25. How can market intelligence on the cell and gene therapy market add value to an organization's decision-making process? How will the urgency of the pandemic influence the global cell and gene therapy market? What is the reimbursement scenario of the products offered in the global cell and gene therapy market? How is each segment of the global cell and gene therapy market expected to grow during the forecast period?

Cell And Gene Therapy Market : By Current Trends, Industry Analysis, Drivers And Forecast 2022 To 2031

Pooja tbrc 2022-11-10

By Product: Cell Therapy, Gene Therapy 2. By Application: Oncology, Neurological Disorders Table Of Contents 1. Global Cell And Gene Therapy Market Competitive Landscape 21. Key Mergers And Acquisitions In The Cell And Gene Therapy Market 22. Appendix Read Related Reports - https://www.

Rising Prevalence Of Chronic Diseases is likely to drive demand for Cell and Gene Therapy Market

Gauri Cmi 2023-12-01

The global Cell And Gene Therapy Market is estimated to be valued at US$ 18. Porter’s Analysis Threat of new entrants: The high capital requirements and stringent regulatory framework pose significant entry barriers for new players in the Cell And Gene Therapy Market Size. Regional analysis North America is expected to dominate the global cell and gene therapy market during the forecast period. This is attributed to increase funding for research activities, rising adoption of advanced therapies, and presence of key market players in the region. and Novartis AG are two leading players dominating the global market due to their diverse product portfolios and widespread geographic presence.

Gene and Cell Therapy Market Key Players, Share & Forecast Report to 2030

Sofia Kausar 2023-06-14

The major players in the gene and cell therapy market include IQVIA, ICON Plc, Charles River Laboratory, Pharmaceutical Product Development, LLC. Get more information on "Global Gene and Cell Therapy Market Research Report" by requesting FREE Sample Copy at https://www. The cell and gene therapy market is expected to increase in the future due to rising cancer and chronic illness prevalence, increasing elderly population, rising focus on cell and gene therapy, and rising healthcare spending. Browse Global Gene and Cell Therapy Market Research Report with detailed TOC at https://www. Purchase Complete Global Gene and Cell Therapy Market Research Report at https://www.

WHO TO FOLLOW